Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid.
about
Reawakening retrocyclins: ancestral human defensins active against HIV-1The major bactericidal activity of human seminal plasma is zinc-dependent and derived from fragmentation of the semenogelinsThe Role of Cationic Polypeptides in Modulating HIV-1 Infection of the Cervicovaginal MucosaResearch gaps in defining the biological link between HIV risk and hormonal contraceptionPolyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infectionNon-Cationic Proteins Are Associated with HIV Neutralizing Activity in Genital Secretions of Female Sex WorkersHIV-neutralizing activity of cationic polypeptides in cervicovaginal secretions of women in HIV-serodiscordant relationshipsPostcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trialsAnti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodiesHIV-Enhancing and HIV-Inhibiting Properties of Cationic Peptides and Proteins.A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gel.A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics.Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediatorsThe effects of reproductive hormones on the physical properties of cervicovaginal fluid.A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency.Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infectionSelective impact of HIV disease progression on the innate immune system in the human female reproductive tract.Proteomic analysis of menstrual blood.Development of an in vitro alternative assay method for vaginal irritation.Inhibition of HIV-1 infection by human α-defensin-5, a natural antimicrobial peptide expressed in the genital and intestinal mucosae.Acceptability and feasibility of repeated mucosal specimen collection in clinical trial participants in Kenya.Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.Anti-HIV-1 activity of elafin depends on its nuclear localization and altered innate immune activation in female genital epithelial cells.Neisseria gonorrhoeae-induced human defensins 5 and 6 increase HIV infectivity: role in enhanced transmission.Female genital tract secretions and semen impact the development of microbicides for the prevention of HIV and other sexually transmitted infections.Comprehensive proteomic analysis of human cervical-vaginal fluid using colposcopy samples.Linkage of T3 and Cpa pilins in the Streptococcus pyogenes M3 pilus.Anti-HIV activity of human defensin 5 in primary CD4+ T cells under serum-deprived conditions is a consequence of defensin-mediated cytotoxicityReversible deficiency of antimicrobial polypeptides in bacterial vaginosisInnate immunity in the vagina (Part II): Anti-HIV activity and antiviral content of human vaginal secretionsCharacterization of the retrocyclin analogue RC-101 as a preventative of Staphylococcus aureus nasal colonizationCross-Sectional Analysis of Selected Genital Tract Immunological Markers and Molecular Vaginal Microbiota in Sub-Saharan African Women, with Relevance to HIV Risk and Prevention.Cationic polypeptides contribute to the anti-HIV-1 activity of human seminal plasma.Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cellsHIV-Enhancing Factors Are Secreted by Reproductive Epithelia upon Inoculation with Bacterial Vaginosis-Associated Bacteria.The Effects of Hormones and Vaginal Microflora on the Glycome of the Female Genital Tract: Cervical-Vaginal FluidExpression of hemoglobin-α and β subunits in human vaginal epithelial cells and their functional significanceBacterial Vaginosis and Subclinical Markers of Genital Tract Inflammation and Mucosal Immunity.Genital tract viral load in HIV Type 1-positive women correlates with specific cytokine levels in cervical-vaginal secretions but is not a determinant of infectious virus or anti-HIV activity.Association of High-Risk Human Papillomavirus with Genital Tract Mucosal Immune Factors in HIV-Infected Women.
P2860
Q21145822-979E98D4-6D8B-40B3-8BF4-E058D671CF9AQ24324505-97239C95-2091-40D5-A30A-743251D54045Q27000032-09B5B4F0-151D-490C-9DA0-20065FBE617CQ27002559-6466368A-BB94-4EA8-ADCF-17059F84C312Q28489042-3B2C2723-8B78-4526-8C8B-1FBDF36ADE1FQ28548507-7A59747D-2636-46EC-A89A-9BE09CFE73B6Q28731648-7E86FE85-6F36-4BBD-8507-E42EB824AED7Q28749211-4E4A416D-DD02-4F3E-931A-B0F29370E1DAQ33627673-B0BB8D31-7B5F-4339-B226-29964C2C9940Q33753950-F71FD92B-ABD0-4A69-91E7-02E6BEE1725DQ33808638-16A45920-F5C7-4FDA-A0BE-30ED90F66A53Q33933628-44D49573-801B-4F27-A7A3-E03811AC044BQ33999185-A76D3ED3-CC16-481D-AA7D-E88E0F8745C6Q34111702-1E45B228-3FA3-4281-9D2F-0185AA08BFAEQ34136695-832063F4-5215-48F9-A051-FD90261013FAQ34285096-1E86E7A2-0165-42E5-9275-74DB33E09E50Q34295695-EFDB0340-6B2A-41C5-AD4F-7966B6848EBFQ34347737-1D459C84-29FE-4248-B326-2BDE35DA1EB6Q34414296-D927A29C-99BF-4399-98DC-A6F614BEBFEDQ34428345-B4D13434-4B64-4BAA-83E3-AB615718011DQ34434160-30DF69B7-1D37-4178-B3ED-E6B64A0B0B6DQ34467932-1870DD6F-03AC-4AD0-9549-E0BA28A89AB7Q34541093-9B7D4143-F990-4D94-84A3-3C86010B0B42Q34589778-6582ED1D-43E2-43DD-9E9D-181DE6BB8F64Q34680240-0D5A7663-6E5F-412E-8ED4-FE517B9BB409Q34976381-7CAC3576-DE94-4F45-BCB5-7EA09650AF68Q34980395-9AB591CA-E643-425C-9956-C56AC893AB08Q35006153-24F82BDC-1B1A-4BFC-830F-36B9619C547FQ35073965-91127768-98B6-4A34-B346-1F524D9DCD86Q35078336-01F26194-B66F-4F8F-B186-F95598177D3BQ35363804-290F9576-4645-4349-9AE5-BBE75FCA61DFQ35548029-02E087EC-DBF0-497E-9944-E68AFACC17DBQ35609521-3D833103-AA88-457F-ADE7-6CCD7E627098Q35868058-7206C05B-EAE1-4B4B-9811-BBF667F9CDFAQ35892272-A52B0917-7E12-48F8-84E6-BFCF74A0EB95Q36082673-0BBF9D30-A94F-43EA-9724-2D7D3C8BAC34Q36274012-C8C7C4FA-68B0-4A97-8CC4-81B83BCD37FCQ36294698-FC925C98-7E46-4A19-B0D4-139F28B2E916Q36358905-E454542D-378E-46E4-8451-CF575DFEC413Q36471518-5636DF23-5A6D-461A-8E00-1DF84680E127
P2860
Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid.
description
2005 nî lūn-bûn
@nan
2005 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid.
@ast
Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid.
@en
type
label
Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid.
@ast
Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid.
@en
prefLabel
Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid.
@ast
Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid.
@en
P2093
P1476
Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid.
@en
P2093
Alexander M Cole
Amy L Cole
Nitya Venkataraman
Pavel Svoboda
P304
P356
10.4049/JIMMUNOL.175.11.7560
P407
P577
2005-12-01T00:00:00Z